Are you Dr. Lencioni?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Office
1475 Nw 12th Ave
Miami, FL 33136Phone+1 305-243-1343
Summary
- Dr. Riccardo Lencioni, MD is a radiologist in Miami, Florida. He is affiliated with UMHC-Sylvester Comprehensive Cancer Center and University of Miami Hospital.
Clinical Trials
- RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry Start of enrollment: 2018 Feb 23
- A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma Start of enrollment: 2018 Nov 30
Publications & Presentations
PubMed
- 2398 citationsHepatocellular carcinoma.Josep M Llovet, Robin Kate Kelley, Augusto Villanueva, Amit G Singal, Eli Pikarsky
Nature Reviews. Disease Primers. 2021-01-21 - 321 citationsmRECIST for HCC: Performance and novel refinements.Josep M. Llovet, Riccardo Lencioni
Journal of Hepatology. 2020-02-01 - 408 citationsLocoregional therapies in the era of molecular and immune treatments for hepatocellular carcinomaJosep M. Llovet, Thierry de Baere, Laura Kulik, Philipp K. Haber, Tim F. Greten
Nature Reviews. Gastroenterology & Hepatology. 2021-01-28
Press Mentions
Locoregional Therapies in the Era of Molecular and Immune Treatments for Hepatocellular CarcinomaJanuary 28th, 2021
Hepatocellular CarcinomaJanuary 21st, 2021
Principal Investigator Professor Riccardo Lencioni Presents Celsion ThermoDox® Trial Data at SPECTRUM 2020 Interventional Oncology ConferenceFebruary 4th, 2020- Join now to see all
